secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2026-09-11T22:16:08+00:00
Accession:  0001520138-26-000391
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioVie enters ATM sales agreement to sell up to $6.46M of common stock
----------------------------------------------------------------------

- Entered sales agreement with A.G.P./Alliance Global Partners for at-the-market offering on Sept 11, 2026.
- May issue and sell Class A common stock with aggregate offering price up to $6,464,341.
- Agent commission of 3.0% of gross proceeds; proceeds for general corporate purposes.
- Offering under effective Form S-3 registration statement (effective June 29, 2026).
- Sales may be made directly on Nasdaq Capital Market; no obligation to sell any shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013826000391/0001520138-26-000391-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013826000391/bivi-20260911_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-26-000391

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer